Tachykardiomyopathie

Als Tachykardiomyopathie (TMP) bezeichnet man die Ausbildung einer Herzinsuffizienz aufgrund einer Herzrhythmusstörung – ausgelöst durch schnelle und/oder unregelmäßige Kammeraktionen. Die TMP ist eine prinzipiell (zumindest teilweise) reversible Erkrankung, sodass der Kontrolle der Arrhythmie eine zentrale Bedeutung zukommt.

Abstract

Tachycardiomyopathy (TMP) is the development of heart failure due to a cardiac arrhythmia – triggered by rapid and/or irregular ventricular actions. TMP is in principle a (at least partially) reversible disease, so that control of the arrhythmia is of central importance. This article provides an overview of the causes, diagnosis and therapy.

Schlüsselwörter

Tachykardiomyopathie - Herzinsuffizienz - Vorhofflimmern - Extrasystolen

Key words

tachycardiomyopathy - heart failure - atrial fibrillation - extrasystoles

• Literatur

• 1 Donghua Z, Jian P, Zhongbo X. et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia. J Interv Card Electrophysiol 2013; 36: 27-32
• 2 Maisel WH, Warner Stevenson L. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91 (06) 2D-8D
• 3 Shinbane JS, Wood MA, Jensen DN. et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29: 709-715
• 4 Van Gelder IC, Groenveld HF, Crijns HJ. et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362: 1363-1373
• 5 Armstrong PW, Stopps TP, Ford SE. et al. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 1986; 74: 1075-1084
• 6 Ellis ER, Josephson ME. Heart Failure and Tachycardia-Induced Cardiomyopathy. Curr Heart Fail Rep 2013; 10: 296-306
• 7 Kajstura J, Zhang X, Liu Y. et al. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995; 92: 2306-2317
• 8 Mueller KAL, Heinzmann D, Klingel K. et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol 2017; 69: 2160-2172
• 9 Marrouche NF, Brachmann J, Andresen D. et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 2018; 378: 417-427
• 10 Baman TS, Lange DC, Ilg KJ. et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010; 7: 865-869
• 11 Voskoboinik A, Hadjis A, Alhede C. et al. Predictors of adverse outcome in patients with frequent premature ventricular complexes: The ABC‑VT risk score. Heart Rhythm 2020; 17: 1066-1074
• 12 Prabhu S, Taylor AJ, Costello BT. et al. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study. J Am Coll Cardiol 2017; 70: 1949-1961
• 13 Hindricks G, Potpara T, Dagres N. ESC Scientific Document Group. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42: 373-498
• 14 Zang M, Zhang T, Mao J. et al. Beneficial effects of catheter ablation of frequent premature ventricular complexes on left ventricular function. Heart 2014; 100: 787-793
• 15 Priori SG, Blomström-Lundqvist C, Mazzanti A. ESC Scientific Document Group. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793-2867
• 16 Gossage AM, Braxton Hicks JA. On auricular fibrillation. QJM 1913; os6: 435-440
• 17 Di Biase L, Mohanty P, Mohanty S. et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation 2016; 133: 1637-1644
• 18 Fenelson G, Wijns W, Andries E. et al. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 1996; 19: 95-106
• 19 Kanei Y, Friedman M, Ogawa N. et al. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol 2008; 13: 81-85